TITLE

EDITOR'S QUIZ: GI SNAPSHOT

PUB. DATE
May 2006
SOURCE
Gut;May2006, Vol. 55 Issue 5, p618
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quiz concerning the cholestatic hepatitis with marked thrombocytopenia is presented.
ACCESSION #
20739309

 

Related Articles

  • Trombositopeni ile Bulgu Veren Akut Hepatit A Enfeksiyonu: Olgu Sunumu. Yıldırım, Zuhal Keskin; Büyükavcı, Mustafa // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Jun2011, Vol. 5 Issue 2, p80 

    Acute hepatitis such as hepatitis B virus, hepatitis C virus, parvovirus, Ebstein-Barr virus can occur with many viruses. Acute hepatitis due to hepatitis A virus in children is a common, usually self-limiting disease with recovery. Although other viral hepatitis forms occur,with extra hepatic...

  • Peginterferon-α-2b.  // Reactions Weekly;5/21/2011, Issue 1352, p30 

    The article describes the case of a 28-year-old man who developed thrombocytopenia during treatment with peginterferon-α-2b for chronic hepatitis C.

  • Peginterferon.  // Reactions Weekly;8/14/2010, Issue 1314, p34 

    The article describes the case of a 37-year-old woman who experienced severe thrombocytopenia while receiving peginterferon for chronic hepatitis C.

  • Hepatitis C increased risk for immune thrombocytopenic purpura. Jacob, Harry S. // Hem/Onc Today;3/25/2009, Vol. 10 Issue 6, p6 

    The article discusses a study," published in a 2009 issue of "Archives of Internal Medicine," which examined the risk for developing immune thrombocytopenic purpura in patients with hepatitis C.

  • IDIOPATHIC THROMBOCYTOPENIC PURPURA DURING INTERFERON-α2B TREATMENT FOR CHRONIC HEPATITIS. Murakami, Carol S.; Zeller, Kathleen; Bodenheimer Jr., Henry C.; Lee, William M. // American Journal of Gastroenterology;Dec1994, Vol. 89 Issue 12, p2244 

    Presents a case study of severe thrombocytopenia that occurred in patients with chronic hepatitis during interferon treatment. Clinical history of the patients; Management of the disease; Overview of thrombocytopenia.

  • THE BURDEN OF CONGENITAL RUBELLA SYNDROME. Cooper, Louis Z. // Vaccines: Preventing Disease & Protecting Health;2004, p53 

    Information on congenital rubella syndrome (CRS) from a chapter of the book "Vaccines: Preventing Diseases & Protecting Health" is presented. The neonatal manifestations of CRS are identified including thrombocytopenic purpura, hepatitis and radiographic evidence of disturbed bone growth....

  • Peginterferon/ribavirin.  // Reactions Weekly;9/22/2007, Issue 1170, p27 

    The article describes two cases of patients who developed thrombocytopenia while receiving peginterferon and ribavirin for chronic hepatitis C. The patients developed severe thrombocytopenia after receiving peginterferon and ribavirin. The platelet counts of both patients decreased after taking...

  • Thombocytopenia (T) in patients with chronic hepatitis C: management with interleukin-11 (IL11). Rangaraj, Venkat; Mendenhall, Charles; Goldberg, Stephen // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS82 

    An abstract of the article "Thombocytopenia (T) in Patients With Chronic Hepatitis C: Management With Interleukin-11 (IL11)," by Venkat Rangaraj, Charles Mendenhall and Goldberg Stephen is presented.

  • Reducing Harm Associated with Anticoagulation. Hursting, Marcie J.; Soffer, Joseph // Drug Safety;2009, Vol. 32 Issue 3, p203 

    Argatroban is a hepatically metabolized, direct thrombin inhibitor used for prophylaxis or treatment of thrombosis in heparin-induced thrombocytopenia (HIT) and for patients with or at risk of HIT undergoing percutaneous coronary intervention (PCI). The objective of this review is to summarize...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics